SPATA18 and cancer: These results suggested the tumor suppressive effects of Spata18 during intestinal adenocarcinoma development; inactivation of Spata18-regulated mitochondrial quality control leads to accumulation of unhealthy mitochondria and increased mitochondrial ROS generation, which probably promotes cancer development and aggressiveness [9].